Price review kicks off as foreign makers find it harder to justify investments
Medtronic’s robotic surgery system guides the placement of custom rods, right, during spinal surgery. (Photos by Mitsuru Obe)
MITSURU OBE
December 2, 2025 12:01 JST
TOKYO — Global medical technology companies may be experiencing growing demand for health care products and services in rapidly aging Japan, but their optimism is being tempered by tightly controlled prices, continued cost inflation and a falling yen that diminishes their dollar-based revenue.